BRAIN Biotech AG / Fundamentals
Income statement
- Net revenue
€67.74M - Cost of goods sold
€44.63M - Gross profit
€23.11M - SG&A expenses
€10.95M - R&D expenses
€0.00 - EBITDA
-€4.67M - D&A
€6.04M - EBIT
-€11.92M - Interest expenses
€2.88M - EBT
-€14.74M - Tax expenses
€48.00K - Net income
-€15.16M
Cash flow statement
- Net deferred tax
-€161.00K - Non-cash items
€1.05M - Changes in working capital
€1.18M - Operating cash flow
-€6.92M - Capex
€9.00K - Other investing cash flow
-€1.56M - Net investing cash flow
-€1.95M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€21.14M - Net financing cash flow
€21.14M - Foreign exchange effects
€121.00K - Net change in cash
€12.47M - Cash at end of period
€17.82M - Free cash flow
-€6.91M
Balance sheet
- Cash and cash equivalents
€0.00 - Cash and short-term investments
€0.00 - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€37.11M - Total current assets
€37.11M - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€43.22M - Total non-current assets
€43.22M - Total assets
€80.33M - Accounts payable
€0.00 - Short-term debt
€0.00 - Other current liabilities
€19.80M - Total current liabilities
€19.80M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€50.22M - Total non-current liabilities
€50.22M - Total liabilities
€70.02M - Common stock
€0.00 - Retained earnings
€0.00 - Other equity
€0.00 - Total equity
€9.04M - Total liabilities and shareholders' equity
€79.06M
Company information
- Market capitalization
€41.07M - Employees
296 - Enterprise Value
€45.01M
Company ratios
- Gross margin
-
34.1% Much worse than peer group: 67.6% - EBITDA margin
-
-6.9% Much better than peer group: -112.9% - EBIT margin
-
-17.6% Much better than peer group: -140.8% - EBT margin
-
-21.8% Much better than peer group: -118.7% - Net margin
-
-22.4% Much better than peer group: -141.5% - ROE
-
-167.8% Much worse than peer group: 9.0% - ROA
-
-18.9% Worse than peer group: -7.3% - Asset turnover
-
84.3% Much better than peer group: 38.6% - FCF margin
-
-10.2% Much better than peer group: -198.3% - FCF yield
-16.9% - Efficiency ratio
106.9% - Net sales per employee
-
€228.85K - Net income per employee
-
-€51.22K